Related references
Note: Only part of the references are listed.Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer
Hyman B. Muss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Management of Chemotherapy-Induced Thrombocytopenia: Current Status of Thrombopoietic Agents
Saroj Vadhan-Raj
SEMINARS IN HEMATOLOGY (2009)
Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy
Michelle Shayne et al.
CANCER (2007)
Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: The Cancer and Leukemia Group B experience
Hyman B. Muss et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer
Michael J. Hassett et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Cancer Therapy-Induced Residual Bone Marrow Injury: Mechanisms of Induction and Implication for Therapy
Yong Wang et al.
CURRENT CANCER THERAPY REVIEWS (2006)
The anaemia of cancer: Death by a thousand cuts
JL Spivak
NATURE REVIEWS CANCER (2005)
Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy
A Hurria et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: A nationwide study of community practices
GH Lyman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
The effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on primitive hematopoietic stem cell (PHSC) function and numbers, after chemotherapy
RV Gardner et al.
EXPERIMENTAL HEMATOLOGY (2001)
Epidemiological assessment of drug-induced disease
DW Kaufman et al.
LANCET (2000)